Sector: Cell Line Development, ImagingRole: Developed the strategic sales and marketing planSold first systems to early adopters in US and EuropeBased on initial success, developed next level strategy for "early majority" customers.Developed global distribution and routes to marketDeveloping plans for product extensions and new products for cell line development

Interim consulting which performs the outsourcing of all commercial activities for a "portfolio" of spin-offs, early stage and medium-sized technology companies in the Med Tech and Pharma Tools sectors. This is an attractive option for small businesses to get the highest calibre resource but avoid the overhead of a full-time position or sales teamLocation: all UK and Europe-wideWhat we can offer:- Define the commercial strategy (or redefine) and initiate implementation and execution- Interim roles as COO, Commercial Director, VP Sales & Marketing, Business Development, Product Management- NED roles- Voice of the customer projects- Due diligence-Company repair work where strategy has gone wrong and needs course correction- Establishing a new sales office, subsidiary, infrastructure or sales team in the UK for new or overseas companies- Establishing direct and indirect (Distributors) sales channels-Writing and executing business plans-Projects to mentor scientists through to commercial value proposition and viabilityAvailability:full-time or part-time consulting contracts or Commercial NED rolesSpecialties: Commercial Strategy and business development

Sectors: Pharma Services; 3-D cell culture; liver hepatotoxicity, infectious diseasesTaylormade Sales clientRole: Build on strong validated data from early customers using the in vitro liver model platform.Develop commercial strategies, sales tools and pipeline for "early majority" customers

Sector: Med TechTaylormade Sales ClientRole: write the business plan to support next round of funding.

Sectors: Protein biosensors, microfluidics, biomaterials, nanotechnologyTaylormade Sales clientRoles: Establishing all sales and marketing functions for new biosensor company.Establishing new sales channels directly in US and via distributors in Europe and Asia-Pacific.Major achievement: establishing the technology as a displacement technology versus SPR and making first sales to major German-Swiss Pharma

Sector: Chemistry, Flow Cytometry, IVDOut-licensing novel Nobel Prize-winning polymer chemistry which significantly boosts conventional fluorescence labels eiminating many of the drawbacks of incumbent labelling approaches (phycobiliproteins, quantum dots, chemiluminescence). Major implications for immuno and molecular diagnostics.Responsible for all Commercial and Business Development activities.Major achievement - Deal closures - wrote and executed the licensing agreements for the technology and field of use; these resulted in an exit sale of the company in 2012 to Beckton Dickinson

Sector: BioreactorsThis was a Board position.Establishing sales and marketing infrastructure for early-stage companyIncluding routes to market via distributors in Europe and USCompany was unable to secure next round of funding and went into liquidation in March 2008

Sector: Genomics, Proteomics, Cell Biology, Therapeutic Antibodies, ImagingResponsible for switch in product range from genomics to cell biology using core strengths of Genetix.Re-built US sales team and infrastructure.Changed customer base from academic to industrial and moved sales process to be based upon return on investment proposals.Managed a sales and marketing team of 35 peopleSignificantly improved margins on instruments to over 70%Major achievement - developed and launched a new product called ClonePixFL which changed the face of cell line development, changed the business of Genetix and led to the sale of the Company to Danahar

Sector: genomics, proteomicsResponsible for global business strategy, sales and marketing of the complete proteomics portfolio from PerkinElmer.Trebled the turnover of the business unit to $6Mi per annumReporting directly to President of Life Sciences, Patrick Dahlen

Sector: Microarray and ProteomicsResponsible for building sales/marketing/serviceResponsible for integrating this business into Perkin Elmer

Sector: Chromatography, Mass SpectrometryEuropean Sales Person of the Year.Repsonsible for sales and business development for all major pharma accounts in UK.

Sector - HTS and Time-resolved fluorescencePharma specialistEuropean sales person of the year

Trainee Chartered Accountant ACCA